Rhonda L Bitting

Title: Rhonda L Bitting: Innovator in Cancer Research

Introduction

Rhonda L Bitting is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of cancer research, particularly in the detection and isolation of circulating tumor cells (CTCs). With a total of 2 patents, her work has the potential to impact cancer diagnostics and treatment.

Latest Patents

Rhonda L Bitting's latest patents focus on methods for detecting or isolating circulating tumor cells in a subject. These methods include detecting the expression of at least one epithelial mesenchymal transition (EMT) biomarker. Additionally, her patents provide kits for detecting or isolating CTCs, which may include antibodies to at least one EMT biomarker. The patents also outline methods for predicting the responsiveness of a subject to a cancer drug, targeting the delivery of a cancer drug, providing cancer prognosis, and monitoring the progress of cancer in a subject.

Career Highlights

Throughout her career, Rhonda has worked with esteemed organizations such as Duke University and Janssen Diagnostics, LLC. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Rhonda has collaborated with notable colleagues, including Galla Chandra Rao and Mark Carle Connelly. These partnerships have further enhanced her research and innovation in cancer diagnostics.

Conclusion

Rhonda L Bitting is a dedicated inventor whose work in cancer research is paving the way for advancements in diagnostics and treatment. Her innovative methods and patents are crucial in the ongoing fight against cancer.